In vivo Raman spectroscopy of breast tumors prephotodynamic and postphotodynamic therapy
暂无分享,去创建一个
Leandro Raniero | Tanmoy Bhattacharjee | T. Bhattacharjee | L. Raniero | Letícia Corrêa Fontana | Juliana Ferreira-Strixino | J. Ferreira-Strixino | L. C. Fontana
[1] P. Bult,et al. Screen-detected breast cancers have a lower mitotic activity index , 2000, British Journal of Cancer.
[2] Yan Li,et al. Collagen as a double-edged sword in tumor progression , 2013, Tumor Biology.
[3] L. Neumayer,et al. Breast cancer: a review for the general surgeon. , 2013, JAMA surgery.
[4] P. V. van Diest,et al. Expression of growth factors, growth‐inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis , 1998, The Journal of pathology.
[5] C. Krishna,et al. Discrimination of normal, benign, and malignant breast tissues by Raman spectroscopy. , 2006, Biopolymers.
[6] L. Pusztai,et al. Multigene prognostic tests in breast cancer: past, present, future , 2015, Breast Cancer Research.
[7] P. V. van Diest,et al. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. , 1997, The American journal of pathology.
[8] M. Morris,et al. Raman spectroscopy demonstrates prolonged alteration of bone chemical composition following extremity localized irradiation. , 2013, Bone.
[9] Weiqing Xu,et al. The Clinical Application of Raman Spectroscopy for Breast Cancer Detection , 2017 .
[10] C Murali Krishna,et al. Prediction of radiotherapy response in cervix cancer by Raman spectroscopy: A pilot study , 2008, Biopolymers.
[11] C. Krishna,et al. Transcutaneous in vivo Raman spectroscopy: Detection of age-related changes in mouse breast , 2013 .
[12] A. Talari,et al. Raman Spectroscopy of Biological Tissues , 2007 .
[13] R. Skjaerven,et al. Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status. , 1996, Journal of clinical pathology.
[14] R. Dasari,et al. Prospects for in vivo Raman spectroscopy , 2000 .
[15] J. Baak,et al. Prognostic value of proliferation in invasive breast cancer: a review , 2004, Journal of Clinical Pathology.
[16] W. Dietel,et al. Phototransformation of Sensitisers: 3. Implications for Clinical Dosimetry , 1998, Lasers in Medical Science.
[17] Giedre Streckyte,et al. Phototransformations of sensitizers 2. Photoproducts formed in aqueous solutions of porphyrins , 1997 .
[18] Halina Abramczyk,et al. Oncologic photodynamic diagnosis and therapy: confocal Raman/fluorescence imaging of metal phthalocyanines in human breast cancer tissue in vitro. , 2014, The Analyst.
[19] C. Murali Krishna,et al. Swiss bare mice: a suitable model for transcutaneous in vivo Raman spectroscopic studies of breast cancer , 2013, Lasers in Medical Science.
[20] V. B. Kartha,et al. Discrimination of normal, inflammatory, premalignant, and malignant oral tissue: A Raman spectroscopy study , 2006, Biopolymers.
[21] C. Murali Krishna,et al. Tissue Raman Spectroscopy for the Study of Radiation Damage: Brain Irradiation of Mice , 2002, Radiation Research.
[22] Giedre Streckyte,et al. Phototransformations of sensitizers 1. Significance of the nature of the sensitizer in the photobleaching process and photoproduct formation in aqueous solution , 1997 .
[23] C. Krishna,et al. Transcutaneous in vivo Raman spectroscopy of breast tumors and pretumors , 2015 .
[24] H. Abramczyk,et al. Raman imaging in biochemical and biomedical applications. Diagnosis and treatment of breast cancer. , 2013, Chemical reviews.
[25] A. Jirasek,et al. Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy , 2011, Physics in medicine and biology.
[26] B. Wilson,et al. A review of Raman spectroscopy advances with an emphasis on clinical translation challenges in oncology , 2016, Physics in medicine and biology.
[27] B. Angus,et al. A study of interval breast cancer within the NHS breast screening programme , 2000, Journal of clinical pathology.
[28] R. Dasari,et al. Diagnosing breast cancer by using Raman spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] H. Barr,et al. Advances in the clinical application of Raman spectroscopy for cancer diagnostics. , 2013, Photodiagnosis and photodynamic therapy.
[30] Andrei V. Reshetnickov,et al. Novel drug form of chlorin e6 , 2000, BiOS.
[31] R. Dasari,et al. Raman microspectroscopic model of human breast tissue: implications for breast cancer diagnosis in vivo , 2002 .
[32] I. Ellis,et al. Recommendations for HER2 testing in the UK , 2000, Journal of clinical pathology.
[33] Halina Abramczyk,et al. New look inside human breast ducts with Raman imaging. Raman candidates as diagnostic markers for breast cancer prognosis: Mammaglobin, palmitic acid and sphingomyelin. , 2016, Analytica chimica acta.
[34] Marian Cholewa,et al. Application of Raman Spectroscopy and Infrared Spectroscopy in the Identification of Breast Cancer , 2016, Applied spectroscopy.
[35] Zhe Chuan Feng,et al. Raman Spectroscopic Characterization of Human Breast Tissues: Implications for Breast Cancer Diagnosis , 1993 .
[36] M. Schmitt,et al. Advantages and limitations of Raman spectroscopy for molecular diagnostics: an update , 2015, Expert review of molecular diagnostics.
[37] P. V. van Diest,et al. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops , 1998, The Journal of pathology.